Assessing main death pathways in T lymphocytes from HIV infected individuals

Authors

  • Marta Massanella,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Marta Curriu,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Jorge Carrillo,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Elisabet Gómez,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Jordi Puig,

    1. Fundació Lluita contra la SIDA, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Jordi Navarro,

    1. Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    Search for more papers by this author
  • Judith Dalmau,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Javier Martínez-Picado,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    2. ICREA, Barcelona, Spain
    Search for more papers by this author
  • Manel Crespo,

    1. Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    Search for more papers by this author
  • Cecilia Cabrera,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Eugènia Negredo,

    1. Fundació Lluita contra la SIDA, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Bonaventura Clotet,

    1. Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    2. Fundació Lluita contra la SIDA, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author
  • Julià Blanco

    Corresponding author
    • Institut de Recerca de la Sida, IrsiCaixa-HIVACAT, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain
    Search for more papers by this author

Retrovirology Laboratory, Fundació irsiCaixa, Hospital Universitari Germans Trias i Pujol 08916 Badalona, Catalonia, Spain. E-mail: jblanco@irsicaixa.es

Abstract

Increased lymphocyte death is a hallmark of human immunodeficiency virus (HIV) infection. Although virological factors have been linked to this phenomenon, increased cell death rates are still observed in treated individuals in which viral replication is halted. To understand the nature of this remaining altered cell death, we have developed a simple and fast assay to assess major cell death pathways in lymphocytes isolated from HIV-infected individuals. The combination of three factors: (i) antibody staining to identify CD3+CD4+ and CD3+CD8+ cells, (ii) assessment of mitochondrial and plasma membrane function using DiOC6(3) or JC-1 probes and vital dyes, and (iii) caspase inhibition, allowed for the quantification of caspase-independent and -dependent cell death in CD4 and CD8 T cells. The latter mechanism was divided in intrinsic and extrinsic apoptotic pathways according to the sensitivity of the dissipation of mitochondrial membrane potential to Z-VAD-fmk or Q-VD-oPH treatment. Our data show similar results for both caspase inhibitors in treated infected individuals, whereas Q-VD-oPH showed a more potent inhibition in viremic individuals, yielding lower levels of intrinsic apoptosis. Comparison of DiOC6(3) and JC-1 probes yielded similar results in CD4 T cells, allowing for a clear definition of death mechanism in these cells. However, in CD8 T-cells, JC-1 showed heterogeneous staining and detected significantly lower levels of cell death with a higher contribution of intrinsic apoptosis. In conclusion, we provide a simple method to assess CD4 T-cell death mechanisms in HIV-infected individuals. The reasons and consequences of mitochondrial heterogeneity in CD8 T-cells require further evaluation. © 2012 International Society for Advancement of Cytometry

Ancillary